Plant ID: NPO12755
Plant Latin Name: Siphonostegia chinensis
Taxonomy Genus: Siphonostegia
Taxonomy Family: Orobanchaceae
NCBI TaxonomyDB:
374729
Plant-of-the-World-Online:
n.a.
China
MAPK1; | |
CA13; CA12; CA9; | |
ALDH1A1; AKR1B10; AKR1B1; | |
ELANE; | |
APP; MAPT; |
Protein Class | Gene ID | Protein Name | Uniprot ID | Target ChEMBL ID |
---|---|---|---|---|
Cytochrome P450 family 2 | CYP2A6 | Cytochrome P450 2A6 | P11509 | CHEMBL5282 |
Cytochrome P450 family 3 | CYP3A4 | Cytochrome P450 3A4 | P08684 | CHEMBL340 |
Enzyme_unclassified | ALDH1A1 | Aldehyde dehydrogenase 1A1 | P00352 | CHEMBL3577 |
Enzyme_unclassified | AKR1B10 | Aldo-keto reductase family 1 member B10 | O60218 | CHEMBL5983 |
Enzyme_unclassified | AKR1B1 | Aldose reductase | P15121 | CHEMBL1900 |
Lyase | CA13 | Carbonic anhydrase XIII | Q8N1Q1 | CHEMBL3912 |
Lyase | CA12 | Carbonic anhydrase XII | O43570 | CHEMBL3242 |
Lyase | CA9 | Carbonic anhydrase IX | Q16790 | CHEMBL3594 |
Protein Kinase | MAPK1 | MAP kinase ERK2 | P28482 | CHEMBL4040 |
Serine protease | ELANE | Leukocyte elastase | P08246 | CHEMBL248 |
Unclassified | APP | Beta amyloid A4 protein | P05067 | CHEMBL2487 |
Unclassified | MAPT | Microtubule-associated protein tau | P10636 | CHEMBL1293224 |
GO Type | GO Category | Enriched GO Terms | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|
MF | GO:0003824; catalytic activity | GO:0004089; carbonate dehydratase activity | 8.300E-08 | 9.037E-04 | CA12, CA13, CA9 |
BP | GO:0008152; metabolic process | GO:0008202; steroid metabolic process | 2.417E-07 | 1.754E-03 | AKR1B1, AKR1B10, APP, CYP2A6, CYP3A4 |
BP | GO:0008152; metabolic process | GO:0006066; alcohol metabolic process | 4.191E-07 | 2.282E-03 | AKR1B1, AKR1B10, ALDH1A1, APP, CYP3A4 |
BP | GO:0008152; metabolic process | GO:0006730; one-carbon metabolic process | 1.293E-06 | 5.631E-03 | CA12, CA13, CA9 |
BP | GO:0051179; localization | GO:0015701; bicarbonate transport | 2.392E-06 | 7.439E-03 | CA12, CA13, CA9 |
MF | GO:0003824; catalytic activity | GO:0016903; oxidoreductase activity, acting on the aldehyde or oxo group of donors | 2.392E-06 | 7.439E-03 | AKR1B1, AKR1B10, ALDH1A1 |
BP | GO:0008152; metabolic process | GO:0044597; daunorubicin metabolic process | 9.886E-06 | 1.296E-02 | AKR1B1, AKR1B10 |
MF | GO:0003824; catalytic activity | GO:0001758; retinal dehydrogenase activity | 7.417E-06 | 1.296E-02 | AKR1B10, ALDH1A1 |
CC | GO:0044464; cell part | GO:0032838; plasma membrane bounded cell projection cytoplasm | 8.581E-06 | 1.296E-02 | AKR1B1, MAPK1, MAPT |
MF | GO:0005488; binding | GO:0046914; transition metal ion binding | 1.983E-05 | 2.056E-02 | APP, CA12, CA13, CA9, CYP2A6, CYP3A4 |
CC | Unclassified; | GO:0097386; glial cell projection | 4.787E-05 | 3.754E-02 | AKR1B1, APP |
Pathway Category Top Level | Pathway Category Second Level | Pathway ID | Pathway Name | p-Value | Adjusted p-Value | Enriched Genes |
---|---|---|---|---|---|---|
09100 Metabolism | 09102 Energy metabolism | hsa00910 | Nitrogen metabolism | 1.117E-07 | 1.150E-05 | CA12, CA9, CA13 |
09100 Metabolism | 09108 Metabolism of cofactors and vitamins | hsa00830 | Retinol metabolism | 7.059E-06 | 3.635E-04 | CYP2A6, ALDH1A1, CYP3A4 |
09160 Human Diseases | 09163 Neurodegenerative diseases | hsa05010 | Alzheimer's disease | 1.211E-04 | 3.338E-03 | APP, MAPK1, MAPT |
Unclassified | Unclassified | hsa01100 | Metabolic pathways | 4.965E-04 | 6.341E-03 | CYP2A6, AKR1B10, ALDH1A1, AKR1B1, CYP3A4 |
09100 Metabolism | 09101 Carbohydrate metabolism | hsa00040 | Pentose and glucuronate interconversions | 2.056E-04 | 3.529E-03 | AKR1B10, AKR1B1 |
09100 Metabolism | 09101 Carbohydrate metabolism | hsa00052 | Galactose metabolism | 1.422E-04 | 3.338E-03 | AKR1B10, AKR1B1 |
09100 Metabolism | 09111 Xenobiotics biodegradation and metabolism | hsa00983 | Drug metabolism - other enzymes | 3.366E-04 | 4.953E-03 | CYP2A6, CYP3A4 |
09100 Metabolism | 09101 Carbohydrate metabolism | hsa00051 | Fructose and mannose metabolism | 1.621E-04 | 3.338E-03 | AKR1B10, AKR1B1 |
09100 Metabolism | 09103 Lipid metabolism | hsa00561 | Glycerolipid metabolism | 5.540E-04 | 6.341E-03 | AKR1B10, AKR1B1 |
09100 Metabolism | 09111 Xenobiotics biodegradation and metabolism | hsa00982 | Drug metabolism - cytochrome P450 | 7.571E-04 | 7.798E-03 | CYP2A6, CYP3A4 |
09100 Metabolism | 09111 Xenobiotics biodegradation and metabolism | hsa00980 | Metabolism of xenobiotics by cytochrome P450 | 8.470E-04 | 7.931E-03 | CYP2A6, CYP3A4 |
09160 Human Diseases | 09161 Cancers | hsa05204 | Chemical carcinogenesis | 1.067E-03 | 9.160E-03 | CYP2A6, CYP3A4 |
ICD10 Disease Category | Disease Name | ICD10 Code | Associated Disease Targets (Association Ref: TTD database) |
---|---|---|---|
F01-F99: Mental, Behavioral and Neurodevelopmental disorders | Mild cognitive impairment | F06.7 | APP; |
C00-D49: Neoplasms | Head and neck cancer | C07-C14, C32-C33 | AKR1B1; |
I00-I99: Diseases of the circulatory system | Neurological disease | I21, I22, R52, R52.1-R52.2, R60.9, G89 | APP; |
C00-D49: Neoplasms | Solid tumours | C00-D48 | MAPK1; |
G00-G99: Diseases of the nervous system G00-G99 | Mild to moderate alzheimer disease | G30 | APP; |
H00-H59: Diseases of the eye and adnexa | Macular degeneration | H35.3 | APP; |
E00-E89: Endocrine, nutritional and metabolic diseases | Amyloidosis | E85 | APP; |
I00-I99: Diseases of the circulatory system | Cerebral amyloid angiopathy | I68.0 | APP; |
M00-M99: Diseases of the musculoskeletal system and connective tissue | Rheumatoid arthritis | M05-M06 | AKR1B1; |
G00-G99: Diseases of the nervous system G00-G99 | Diagnostic imaging | G30, I73.9 | APP; |
E00-E89: Endocrine, nutritional and metabolic diseases | Diabetic neuropathy | E11.40 | AKR1B1; |
E00-E89: Endocrine, nutritional and metabolic diseases | Diabetic complication | E08-E13 | AKR1B1; |
E00-E89: Endocrine, nutritional and metabolic diseases | Diabetic cataract | E10.36, E11.36 | AKR1B1; |
E00-E89: Endocrine, nutritional and metabolic diseases | Diabetes | E23.2, N25.1 | AKR1B1; |
G00-G99: Diseases of the nervous system G00-G99 | Alzheimer disease | G30 | APP; |
H00-H59: Diseases of the eye and adnexa | Age related macular degeneration | H35.3 | APP; |
M00-M99: Diseases of the musculoskeletal system and connective tissue | Gout | M10 | AKR1B1; |
C00-D49: Neoplasms | Glioma | C71 | APP; |
NA: NA | Geographic retinal atrophy | NA | APP; |
H00-H59: Diseases of the eye and adnexa | Glaucoma | H40-H42 | AKR1B1; |
S00-T88: Injury, poisoning and certain other consequences of external causes | Brain injury | S09.90 | APP; |
I00-I99: Diseases of the circulatory system | Restenosis | I51.89 | MAPK1; |
C00-D49: Neoplasms | Cancer | C00-C96 | MAPK1; APP; |